Systematic review of 30 studies (2122 patients) in large B-cell lymphoma: by indirect comparison, pooled complete response was 53.7% for CAR-T after bispecific antibodies (4 studies) vs 29.4% for bispecifics after CAR-T (18 studies). Small samples.
Meta-analysisn = 2,122
Sorin et al. Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis